EN ISO 10993-6-2009

Biological evaluation of medical devices - Part 6: Tests for local effects after implantation

EN ISO 10993-6-2009 发布历史

This part of ISO 10993 specifies test methods for the assessment of the local effects after implantation of biomaterials intended for use in medical devices. This part of ISO 10993 applies to materials that are: ?? solid and non-biodegradable; ?? degradable and/or resorbable; ?? non-solid@ such as porous materials@ liquids@ pastes and particulates. The test specimen is implanted into a site and animal species appropriate for the evaluation of the biological safety of the material. These implantation tests are not intended to evaluate or determine the performance of the test specimen in terms of mechanical or functional loading. This part of ISO 10993 may also be applied to medical devices that are intended to be used topically in clinical indications where the surface or lining may have been breached@ in order to evaluate local tissue responses. The local effects are evaluated by a comparison of the tissue response caused by a test specimen to that caused by control materials used in medical devices of which the clinical acceptability and biocompatibility characteristics have been established. The objective of the test methods is to characterize the history and evolution of the tissue response after implantation of a medical device/biomaterial including final integration or resorption/degradation of the material. In particular for degradable esorbable materials the degradation characteristics of the material and the resulting tissue response should be determined. This part of ISO 10993 does not deal with systemic toxicity@ carcinogenicity@ teratogenicity or mutagenicity. However@ the long-term implantation studies intended for evaluation of local biological effects may provide insight into some of these properties. Systemic toxicity studies conducted by implantation may satisfy the requirements of this part of ISO 10993.

EN ISO 10993-6-2009由CEN - European Committee for Standardization 发布于 2009-05-01，并于 2016-12-23 实施。

EN ISO 10993-6-2009的历代版本如下：

• 2007年04月01日 EN ISO 10993-6-2007
• 2009年05月01日 EN ISO 10993-6-2009
• 2016年12月 EN ISO 10993-6-2016 医疗器械生物学评价第6部分:植入后局部反应试验(ISO 10993-6:2016)

非常抱歉，我们暂时无法提供预览，您可以试试： 免费下载 EN ISO 10993-6-2009 前三页，或者稍后再访问。

注意： 点击下载后，生成下载文件时间比较长，请耐心等待......

标准号

EN ISO 10993-6-2009

发布日期

2009年05月01日

实施日期

2016年12月23日

废止日期

无

中国标准分类号

/

国际标准分类号

/

发布单位

CEN - European Committee for Standardization

引用标准

32

适用范围

This part of ISO 10993 specifies test methods for the assessment of the local effects after implantation of biomaterials intended for use in medical devices. This part of ISO 10993 applies to materials that are: ?? solid and non-biodegradable; ?? degradable and/or resorbable; ?? non-solid@ such as porous materials@ liquids@ pastes and particulates. The test specimen is implanted into a site and animal species appropriate for the evaluation of the biological safety of the material. These implantation tests are not intended to evaluate or determine the performance of the test specimen in terms of mechanical or functional loading. This part of ISO 10993 may also be applied to medical devices that are intended to be used topically in clinical indications where the surface or lining may have been breached@ in order to evaluate local tissue responses. The local effects are evaluated by a comparison of the tissue response caused by a test specimen to that caused by control materials used in medical devices of which the clinical acceptability and biocompatibility characteristics have been established. The objective of the test methods is to characterize the history and evolution of the tissue response after implantation of a medical device/biomaterial including final integration or resorption/degradation of the material. In particular for degradable esorbable materials the degradation characteristics of the material and the resulting tissue response should be determined. This part of ISO 10993 does not deal with systemic toxicity@ carcinogenicity@ teratogenicity or mutagenicity. However@ the long-term implantation studies intended for evaluation of local biological effects may provide insight into some of these properties. Systemic toxicity studies conducted by implantation may satisfy the requirements of this part of ISO 10993.

EN ISO 10993-6-2009系列标准

谁引用了EN ISO 10993-6-2009 更多引用